12 and older, any sex, with Heart Failure NYHA Class II or Heart Failure NYHA Class III. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Physician Overall Satisfaction With the We Chatt Intervention Based on the Post Clinician SurveyPrimary· 2 weeks (after intervention)
Satisfaction was based on the answers for 12 questions in which clinicians selected from a Likert scale from strongly disagree (1) -Strongly agree (5). The scores ranged from 12-60; higher scores indicated greater satisfaction.
Group
Value
95% CI
Clinicians Intervention
57.4
± 2.7
Patient/Caregiver Overall Satisfaction With the We Chatt Intervention Based on the Patient/Caregiver SurveyPrimary· 2 weeks (after intervention)
Parent/Caregiver completed 12 questions in which participants selected from a Likert scale from Strongly disagree (1) to Strongly agree (5). The scores ranged from 12-60; higher scores indicated greater satisfaction.
Group
Value
95% CI
Patients
49.5
± 5.8
Caregivers
53.4
± 5.2
Physician Satisfaction With the We Chatt Intervention From Physicians Based on the Post Clinician SurveySecondary· 2 weeks (after intervention)
Physicians answered 1 question on a scale from 0 to 10 (with 0 being worst and 10 being best)
Group
Value
95% CI
Clinicians Intervention
9
9 – 9
Patient/Caregiver Satisfaction With the We Chatt Intervention Based on the Patient/Caregiver SurveySecondary· 2 weeks (after intervention)
Patient/Caregiver answered 1 question on a scale from 0 to 10 (with 0 being worst and 10 being best)
Group
Value
95% CI
Patients
9
8 – 9
Caregivers
10
9 – 10
Time (Measured in Minutes) to Complete We Chatt the Intervention by CliniciansSecondary· 30 minutes (approximately)
Number of minutes to complete the intervention was collected on clinician survey.
Group
Value
95% CI
Clinicians Intervention
15
15 – 25
Sponsor's own description
The goal of this study is improving patient-centered communication for young people with advanced heart disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Other recruiting trials for Heart Failure NYHA Class II
Currently open trials in the same condition.
NCT05632432 — Atrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery
· NA
· recruiting
NCT04829617 — Promoting Well-being and Health in Heart Failure
· NA
· recruiting
NCT03180320 — Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)
· NA
· recruiting
Other University of Michigan trials
Trials by the same sponsor.
NCT07536919 — Integrating Care for Hypertension-Diabetes MULTImorbidity in Guatemala Through HEARTS Implementation
· NA
· not yet recruiting
NCT05509842 — Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD)
· NA
· not yet recruiting
NCT06311188 — Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness
· NA
· not yet recruiting
NCT07471646 — Effects of Ramadan Fasting With Exercise on Cardiometabolic Health
· NA
· not yet recruiting
NCT06671925 — A Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults
· NA
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Michigan
Last refreshed: 18 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05835063.